Picture of Enfusion logo

ENFN — Enfusion News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Enfusion Inc reports results for the quarter ended in September 30 - Earnings Summary

* Enfusion Inc  ENFN.N  reported quarterly adjusted earnings
of 5
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 4 cents.  The mean expectation of seven analysts for the
quarter was for earnings of 5 cents per share. Wall Street
expected results to range from 4 cents to 6 cents per share.
    * Revenue rose 15.2% to $51.17 million from a year ago;
analysts
expected $51.66 million. 
    * Enfusion Inc's reported EPS for the quarter was 1 cent​.
    * The company reported quarterly net income of $1.42
million.
    * Enfusion Inc shares had fallen by 8.1% this quarter and
lost 10.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 15.5%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 3 "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "hold"

Wall Street's median 12-month price target for Enfusion Inc is
$9.75 
This summary was machine generated from LSEG data November 5 at
07:46 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.05           0.05           Met
 Jun. 30 2024      0.06           0.05           Missed
 Mar. 31 2024      0.04           0.06           Beat
 Dec. 31 2023      0.05           0.04           Missed

Recent news on Enfusion

See all news